Three University of California San Diego researchers have received prestigious awards through the National Institutes of Health (NIH) High-Risk, High-Reward Research Program, including the Pioneer Award, the program’s top honor.
Five UC San Diego bioengineering graduate students working at the interface of biology, engineering and health have been honored as 2020 Siebel Scholars.
An international team of researchers has discovered a cause for a rare eye disease affecting the macula that leads to loss of central vision, called macular telangiectasia type 2 (MacTel).
Bioengineers and biologists at the University of California San Diego have developed a method to significantly extend the life of gene circuits used to instruct microbes to do things such as produce and deliver drugs, break down chemicals and serve as environmental sensors.
UC San Diego researchers discovered clever tricks to design materials that replicate different levels of perceived softness. The findings provide fundamental insights into designing tactile materials and haptic interfaces that can recreate realistic touch sensations.
Using lasers, engineers have developed a new ceramic welding technology that works in ambient conditions, making it more practical than traditional methods that require melting the parts in a furnace at extremely high temperatures. This could make it possible to build ceramic-encased electronics.
Researchers have discovered the root cause of why lithium metal batteries fail, challenging a long-held belief in the field. The study presents new ways to boost battery performance and brings research a step closer to incorporating lithium anodes into rechargeable batteries.
The University of California San Diego has been named the fourth best public university in the United States by the 2019 Academic Ranking of World Universities (ARWU). The rankings list the campus as the country’s 15th best university and 18th in the world.
UC San Diego School of Medicine has been awarded $9 million to fund research projects using human pluripotent stem cells, CRISPR and human organoids to dissect beta cell defects and create a human cell model of type 1 diabetes aimed at identifying the cellular actions leading to disease onset.